Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.3M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
19.4M
-
Shares change
-
-1.34M
-
Total reported value, excl. options
-
$58.8M
-
Value change
-
-$3.87M
-
Number of buys
-
38
-
Number of sells
-
-44
-
Price
-
$3.03
Significant Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q2 2015
96 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock as of Q2 2015.
ENZO BIOCHEM INC - Common Stock (ENZB) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.4M shares
of 52.3M outstanding shares and own 37.14% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.89M shares), DIMENSIONAL FUND ADVISORS LP (1.72M shares), First Light Asset Management, LLC (1.44M shares), BlackRock Institutional Trust Company, N.A. (1.25M shares), VANGUARD GROUP INC (1.22M shares), RENAISSANCE TECHNOLOGIES LLC (1.18M shares), KOPP INVESTMENT ADVISORS LLC (823K shares), MILLENNIUM MANAGEMENT LLC (778K shares), Clearbridge Investments, LLC (675K shares), and UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (671K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.